Mode VC

David A. Wiersma

Senior Associate atResearch Corporation TechnologiesArizona
Full bioFirm profile

David A. Wiersma is a Senior Associate at Research Corporation Technologies, managing patent development and evaluating intellectual property. He has worked on commercializing pharmaceutical and diagnostic technologies since 1984.

What David can write

Writes checks of$250K to $10M
Comes in atPre-seed, Seed, Series ACan lead the round
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Research Corporation Technologies writes $250K to $10M checks, larger than 33% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Research Corporation Technologies.

Career

  1. Research Corporation
    1984-1987
  2. Research Corporation Technologies · Associate, Life Sciences
    Now
  3. Research Corporation Technologies · Senior Associate
    Now
  4. Sertoli Technologies Inc. · Science Advisory Board
    1996-2006
  5. MetaProbe LLC · Manager
    1997
  6. MetaProbe Inc. · Director
    1997-2004
  7. Alerion Biomedical Inc. · Director
    2004-2007
  8. The University of Arizona · Research Associate, College of Pharmacy
    1982-2006

Focus

biologicsdiagnosticsoncologymetabolic disease

Education

Michigan State University, Ph.D., PharmacologyCalvin College, B.S., Biology-Chemistry

Also at Research Corporation Technologies

Shaun A. KirkpatrickPresident, Biotechnologies
Brad MorieSenior Director, Biotechnologies
Chad W. SouvignierVice President
Paul HoerbeltDirector, Biotechnologies
William KellyAssociate

Partners like David

At firms with a similar stage, sector and check size.

Ann DeWitt
Ann DeWittGeneral Partner, The Engine
Aryeh GanzManaging Partner, Cornucopian Capital
Jack W. Lasersohn
Jack W. LasersohnGeneral Partner, The Vertical Group
Brad Corona
Brad CoronaManaging Director, Vertical Venture Partners
Jamie RutledgeGeneral Partner, Bluelake
Carey Ng, PhD, MBAManaging Director, Mesa Verde Venture Partners

Alert me when Research Corporation Technologies is active

One email when David's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is David A. Wiersma?

David A. Wiersma is a Senior Associate at Research Corporation Technologies, managing patent development and evaluating intellectual property. He has worked on commercializing pharmaceutical and diagnostic technologies since 1984.

How much does David A. Wiersma invest?

David A. Wiersma invests through Research Corporation Technologies, which writes checks of $250K to $10M at pre-seed, seed, series a.

How do I pitch David A. Wiersma?

A warm intro from a founder Research Corporation Technologies backed works best.

What did David A. Wiersma do before Research Corporation Technologies?

Research Corporation; Science Advisory Board at Sertoli Technologies Inc.; Manager at MetaProbe LLC; Director at MetaProbe Inc.; Director at Alerion Biomedical Inc.; Research Associate, College of Pharmacy at The University of Arizona.

Last updated 2026-10-15. Is this you? Ask for a correction.